166 related articles for article (PubMed ID: 32495502)
1. Prognosis of pediatric patients with anicteric and late-onset sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.
Inagaki J; Noguchi M; Fukano R
Pediatr Blood Cancer; 2020 Aug; 67(8):e28412. PubMed ID: 32495502
[TBL] [Abstract][Full Text] [Related]
2. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
[TBL] [Abstract][Full Text] [Related]
3. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
Roeker LE; Kim HT; Glotzbecker B; Nageshwar P; Nikiforow S; Koreth J; Armand P; Cutler C; Alyea EP; Antin JH; Richardson PG; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2019 Jan; 25(1):137-144. PubMed ID: 30081073
[TBL] [Abstract][Full Text] [Related]
4. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.
Yakushijin K; Atsuta Y; Doki N; Yokota A; Kanamori H; Miyamoto T; Ohwada C; Miyamura K; Nawa Y; Kurokawa M; Mizuno I; Mori T; Onizuka M; Taguchi J; Ichinohe T; Yabe H; Morishima Y; Kato K; Suzuki R; Fukuda T
Bone Marrow Transplant; 2016 Mar; 51(3):403-9. PubMed ID: 26595082
[TBL] [Abstract][Full Text] [Related]
5. Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation.
Seifert C; Wittig S; Arndt C; Gruhn B
J Cancer Res Clin Oncol; 2015 May; 141(5):877-85. PubMed ID: 25335953
[TBL] [Abstract][Full Text] [Related]
6. Spectral Doppler Ultrasound Can Help Diagnose Children With Hepatic Sinusoidal Obstructive Syndrome After Hematopoietic Stem Cell Transplantation.
Thumar VD; Vallurupalli VM; Robinson AL; Staggs VS; Shah V; Dalal J; Chan SS
Ultrasound Q; 2020 Mar; 36(1):6-14. PubMed ID: 30921102
[TBL] [Abstract][Full Text] [Related]
7. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Kernan NA; Grupp S; Smith AR; Arai S; Triplett B; Antin JH; Lehmann L; Shore T; Ho VT; Bunin N; Iacobelli M; Liang W; Hume R; Tappe W; Soiffer R; Richardson P
Br J Haematol; 2018 Jun; 181(6):816-827. PubMed ID: 29767845
[TBL] [Abstract][Full Text] [Related]
8. Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.
Cao Z; Villa KF; Lipkin CB; Robinson SB; Nejadnik B; Dvorak CC
J Med Econ; 2017 Aug; 20(8):871-883. PubMed ID: 28562132
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients.
Corbacioglu S; Kernan NA; Pagliuca A; Ryan RJ; Tappe W; Richardson PG
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1342-1349. PubMed ID: 32200121
[TBL] [Abstract][Full Text] [Related]
10. Analysis of laboratory parameters before the occurrence of hepatic sinusoidal obstruction syndrome in children, adolescents, and young adults after hematopoietic stem cell transplantation.
Johann L; Gruhn B
J Cancer Res Clin Oncol; 2024 Jan; 150(1):9. PubMed ID: 38206490
[TBL] [Abstract][Full Text] [Related]
11. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantation.
Cai X; Wu J; Gui RY; Huang QS; Liu X; Qin YZ; Wang JZ; Zeng QZ; Jiang Q; Jiang H; Lu J; Wang JB; Gao L; Zhang X; Zhang HY; Feng J; Zhao XY; Chang YJ; Liu YR; Xu LP; Liu KY; Huang XJ; Zhang XH
Ann Hematol; 2019 Jul; 98(7):1733-1742. PubMed ID: 31053879
[TBL] [Abstract][Full Text] [Related]
13. Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.
Yakushijin K; Ikezoe T; Ohwada C; Kudo K; Okamura H; Goto H; Yabe H; Yasumoto A; Kuwabara H; Fujii S; Kagawa K; Ogata M; Onishi Y; Kohno A; Watamoto K; Uoshima N; Nakamura D; Ota S; Ueda Y; Oyake T; Koike K; Mizuno I; Iida H; Katayama Y; Ago H; Kato K; Okamura A; Kikuta A; Fukuda T
Bone Marrow Transplant; 2019 May; 54(5):674-680. PubMed ID: 30127466
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic recombinant thrombomodulin treatment prevents hepatic sinusoidal obstruction syndrome in high-risk pediatric patients that undergo hematopoietic stem cell transplants.
Yamamoto S; Toyama D; Sugishita Y; Kaneko R; Okamoto N; Koganesawa M; Fujita S; Akiyama K; Matsuno R; Isoyama K
Pediatr Transplant; 2018 Nov; 22(7):e13269. PubMed ID: 30003636
[TBL] [Abstract][Full Text] [Related]
15. Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemia.
Kim H; Lee KH; Sohn SK; Jung CW; Joo YD; Kim SH; Kim BS; Choi JH; Kwak JY; Kim MK; Bae SH; Shin HJ; Won JH; Oh S; Lee WS; Park JH; Yoon SS
Leuk Res; 2013 Oct; 37(10):1241-7. PubMed ID: 23871157
[TBL] [Abstract][Full Text] [Related]
16. Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT.
Battipaglia G; Labopin M; Candoni A; Fanin R; El Cheikh J; Blaise D; Michallet M; Ruggeri A; Contentin N; Ribera JM; Stadler M; Sierra J; von dem Borne PA; Bloor A; Socié G; Nagler A; Mohty M
Bone Marrow Transplant; 2017 Apr; 52(4):592-599. PubMed ID: 28092357
[TBL] [Abstract][Full Text] [Related]
17. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
[TBL] [Abstract][Full Text] [Related]
18. Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH).
González Vicent M; Díaz de Heredia C; González de Pablo J; Molina B; Regueiro A; Pérez Martinez A; Palomo P; López Corral L; García E; Fernández JM; Pérez A; Jiménez MJ; Guerreiro M; Vallejo C; Gallardo AI; López O; Benito A; Marsal J; Duarte M; Bento L; Badell I; Pedraza A; Jiménez Ubieto A; González P; Gómez Centurión I; Costilla L; Beléndez C; Esquirol A; Espigado I; Lavilla E; Díaz MÁ
Eur J Haematol; 2021 Jun; 106(6):842-850. PubMed ID: 33713387
[TBL] [Abstract][Full Text] [Related]
19. Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation.
Park M; Park HJ; Eom HS; Kwon YJ; Park JA; Lim YJ; Yoon JH; Kong SY; Ghim TT; Lee HW; Yun T; Park BK
Ann Transplant; 2013 Jan; 18():36-42. PubMed ID: 23792499
[TBL] [Abstract][Full Text] [Related]
20. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]